Ron Kocak - 08 Apr 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Reporting relationship
VP Controller and PAO
Issuer ticker
RNXT
Reported as of
08 Apr 2025
Net transaction value
+$10,011
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Apr 2025, 19:02:33 UTC
Prior SEC filing
12 Feb 2024
Next SEC filing
16 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ronald Kocak

Key filing fact

Ron Kocak filed Form 4 for RenovoRx, Inc. (RNXT) on 10 Apr 2025.

Key facts

  • This page summarizes Ron Kocak's Form 4 filing for RenovoRx, Inc. (RNXT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Apr 2025, 19:02.

Change

  • Previous filing in this sequence was filed on 12 Feb 2024.
  • Current net transaction value: +$10,011.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RNXT transaction

Common Stock

Purchase

Transaction value
$76
Shares
+95
Change %
Price
$0.8000
Shares after
95
Date
08 Apr 2025
Ownership
Direct
Footnotes
F1
RNXT transaction

Common Stock

Purchase

Transaction value
$4,800
Shares
+6,000
Change %
+6316%
Price
$0.8000
Shares after
6,095
Date
09 Apr 2025
Ownership
Direct
Footnotes
F1
RNXT transaction

Common Stock

Purchase

Transaction value
$5,135
Shares
+6,500
Change %
+107%
Price
$0.7900
Shares after
12,595
Date
10 Apr 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects open market purchases of the Issuer's securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .